1 / 9

Cancer Gene Therapy Market Opportunities Esitimate To Grow At A Significant Rate Throughout The Forecast Period

global cancer gene therapy market accounted for $289 million in 2016, and is estimated to reach $2,082 million by 2023, registering a CAGR of 32.4% from 2017 to 2023.

newmarketindustry
Download Presentation

Cancer Gene Therapy Market Opportunities Esitimate To Grow At A Significant Rate Throughout The Forecast Period

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Met Global Opportunity Analysis and Industry Forecast 2023 Global Opportunity Analysis and Industry Forecast 2023 Global Opportunity Analysis & Industry Forecast, 2014-2022 Opportunity Analysis and Industry Forecast, 2014 - 2022 Global Opportunity Analysis and Industry Forecast, 2014-2022 Opportunity Analysis and Industry Forecast, 2014-2022 Global Opportunity Analysis and Industry Forecast 2030 Global Opportunity Analysis and Industry Forecast, 2014-2022 Global Opportunity Analysis and Industry Forecast, 2014 - 2022 Global Opportunity Analysis and Industry Forecast, 2017-2023 Download Request Sample

  2. Cancer Gene Therapy Market “The positive results displayed by the use of oncolytic virotherapy in the pre-clinical trials could have noteworthy impact on the quality of life of the cancer patient, making it the largest contributor toward the market growth”. SriramRadhakrishnan Team Lead, Healthcare at AMR. Download Request Sample

  3. Cancer Gene Therapy Market According to a new report published by Allied Market Research, titled, Cancer Gene Therapy Market by Therapy and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global cancer gene therapy market accounted for $289 million in 2016, and is estimated to reach $2,082 million by 2023, registering a CAGR of 32.4% from 2017 to 2023. North America is the highest contributor in the cancer gene therapy market in 2016; however, Asia-Pacific is expected to witness the highest growth rate. Download Request Sample

  4. Cancer Gene Therapy Market Cancer gene therapy is an approach for the cancer treatment, where genetically engineered vectors such as viruses are used to transfer or replace a mutated gene (that is causing cancer) with a heathy gene. This technique can be used for both the prevention and treatment of disease. The most commonly used techniques for the treatment using cancer gene therapy includes oncolytic virotherapy, gene transfer, and gene-induced immunotherapy. Download Request Sample

  5. Cancer Gene Therapy Market The rise in prevalence of cancer, ethical acceptance of gene therapy for cancer treatment, and the advancement in this field drive the market growth. In addition, benefits of cancer gene therapy over conventional cancer therapies, increase in government support, and rise in biotechnological funding that encourage the R&D activities for cancer gene therapy fuel the growth of the cancer gene therapy market. However, high cost associated with the treatment and unwanted immune responses are expected to restrain the market growth. Download Request Sample

  6. Cancer Gene Therapy Market In 2016, North America accounted for maximum contribution to the total revenue generated, owing to the high prevalence rate of cancer, presence of high disposable income, and high funding for R&D activities associated with cancer gene therapy. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, attributable to rise in incidence rate of cancer, increase in government initiative to improve healthcare infrastructure, and rise in healthcare expenditure. Download Request Sample

  7. Cancer Gene Therapy Market • Major Companies: • Adaptimmune • GlaxoSmithKline • Bluebird bio Inc. • Merck • Celgene • Shanghai Sunway Biotech • BioCancell • Shenzhen SiBionoGeneTech • SynerGene Therapeutics • OncoGenexPharmaceuticals. Download Request Sample

  8. Cancer Gene Therapy Market • Key Findings of the Cancer Gene Therapy Market: • Gene tranfer segment is projected to grow at the highest rate during the analysis period. • Oncolytic virotherapy segment generated the highest revenue, and is expected to continue its dominance in the future. • North America dominated the global cancer gene therapy market, and is projected to continue its dominance in future. • China is expected to grow highest in the Asia-Pacific region. • Asia-Pacific is expected to be the fastest growing segment during the forecast period. • Send Enquiry on Report: https://www.alliedmarketresearch.com/purchase-enquiry/2605 Download Request Sample

  9. Cancer Gene Therapy Market • Contact: • David Correa • 5933 NE Win Sivers Drive • #205, Portland, OR 97220 • United States • Toll Free (USA/Canada): • +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 • UK: +44-845-528-1300 • Hong Kong: +852-301-84916 • India (Pune): +91-20-66346060 • Fax: +1⟨855⟩550-5975 • help@alliedmarketresearch.com • Web: https://www.alliedmarketresearch.com Download Request Sample

More Related